Seattle Prostate Institute

Appointments 206.386.2356

News & Events


Posted on: 04/29/2015

Xofigo (Alpharadin - Radium 233) is now FDA approved and available through our physicians Stephen M. Eulau, M.D. and Robert K. Takamiya, M.D. at Swedish Cancer Institute (206) 386-2323.

Xofigio represents the latest injectable radiation therapy with survival advantages in patients with hormone refractory prostate cancer with bone mets. 

Visit our PCa COMMENTARY Vol 83 September - October 2013 for more information.

For details and scheduling call the Swedish Cancer Institute (206) 386-2323.

Back to article